Quarterly
Annual
| Unit: USD | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 336,580,000 | 259,432,000 | 235,048,000 | 200,581,000 | 172,740,000 | 157,151,000 | 137,814,000 | 150,874,000 | 149,432,000 | 257,713,000 | 195,457,000 | 97,336,000 | 57,675,000 | 26,392,000 | 232,000 | |
yoy | 67.80% | 50.19% | 49.57% | 32.95% | 15.60% | -39.02% | -29.49% | 55.00% | 159.09% | 876.48% | 84148.71% | |||||
qoq | 29.74% | 10.37% | 16.12% | 9.92% | 14.03% | -8.66% | 0.96% | -42.02% | 31.85% | 100.81% | 68.77% | 118.53% | 11275.86% | |||
costs and expenses | ||||||||||||||||
cost of revenue | 670,197,000 | 531,783,000 | 463,560,000 | 470,355,000 | 404,796,000 | 410,015,000 | 469,722,000 | 555,805,000 | 500,524,000 | 615,291,000 | 492,483,000 | 292,342,000 | 245,970,000 | 151,473,000 | 3,320,000 | |
research and development | 325,305,000 | 273,839,000 | 251,246,000 | 287,170,000 | 284,627,000 | 242,977,000 | 230,758,000 | 233,474,000 | 229,803,000 | 221,294,000 | 213,761,000 | 200,381,000 | 186,076,000 | 163,606,000 | 242,408,000 | |
selling, general and administrative | 283,097,000 | 256,857,000 | 212,175,000 | 210,245,000 | 213,232,000 | 241,026,000 | 189,691,000 | 197,748,000 | 168,770,000 | 170,867,000 | 176,736,000 | 163,812,000 | 223,159,000 | 196,997,000 | 251,554,000 | |
restructuring charges | 20,228,000 | 518,000 | 1,532,000 | 22,496,000 | ||||||||||||
total cost and expenses | 1,278,599,000 | 1,062,479,000 | 926,981,000 | 987,998,000 | 902,655,000 | 894,018,000 | 890,689,000 | 988,559,000 | 921,593,000 | 1,007,452,000 | 882,980,000 | 656,535,000 | 655,205,000 | |||
income from operations | -942,019,000 | -803,047,000 | -691,933,000 | -787,417,000 | -729,915,000 | -736,867,000 | -752,875,000 | -837,685,000 | -772,161,000 | -749,739,000 | -687,523,000 | -559,199,000 | -597,530,000 | -485,684,000 | -497,050,000 | |
yoy | 19.63% | 10.02% | -6.10% | -6.00% | -5.47% | -1.72% | 9.51% | 49.80% | 29.23% | 54.37% | 38.32% | |||||
qoq | 17.31% | 16.06% | 7.88% | -0.94% | -2.13% | -10.12% | 8.49% | 2.99% | 9.05% | 22.95% | -6.41% | 23.03% | -2.29% | |||
operating margin % | -279.88% | -309.54% | -294.38% | -392.57% | -422.55% | -468.89% | -546.30% | -555.22% | -516.73% | -290.92% | -351.75% | -574.50% | -1036.03% | -1840.27% | -214245.69% | |
other income | -10,829,000 | 3,572,000 | 2,965,000 | -5,067,000 | -1,007,000 | 934,000 | -763,000 | -928,000 | 667,000 | -366,000 | 665,000 | 11,188,000 | 942,000 | -742,000 | 249,000 | |
change in fair value of common stock warrant liability | 444,000 | 5,322,000 | 12,861,000 | 7,539,000 | 27,054,000 | 25,279,000 | 60,316,000 | 42,133,000 | -40,802,000 | 255,899,000 | 140,146,000 | 334,843,000 | 523,330,000 | -557,973,000 | -24,787,000 | |
change in fair value of equity securities of a related party | 916,000 | 3,948,000 | -13,453,000 | -9,390,000 | -19,933,000 | |||||||||||
change in fair value of derivative liabilities associated with redeemable convertible preferred stock | -36,375,000 | 111,475,000 | 281,700,000 | |||||||||||||
gain on extinguishment of debt | 116,360,000 | |||||||||||||||
interest income | 34,643,000 | 44,318,000 | 52,209,000 | 54,553,000 | 50,631,000 | 58,680,000 | 66,064,000 | 39,525,000 | 40,005,000 | 29,472,000 | 24,373,000 | |||||
interest expense | -25,571,000 | -23,749,000 | -11,883,000 | -6,673,000 | -7,501,000 | -7,777,000 | -3,340,000 | -6,690,000 | -7,108,000 | -8,075,000 | -7,613,000 | -7,189,000 | -7,705,000 | -1,263,000 | -76,000 | |
total other income | -36,772,000 | 261,246,000 | 324,399,000 | 143,962,000 | 49,244,000 | 83,115,000 | 122,277,000 | 74,040,000 | -7,238,000 | 276,930,000 | 157,571,000 | 338,842,000 | 516,567,000 | -559,978,000 | -27,331,000 | |
income before benefit from income taxes | -978,791,000 | -541,801,000 | -367,534,000 | -643,455,000 | -680,671,000 | -653,752,000 | -630,598,000 | -763,645,000 | -779,399,000 | -472,809,000 | -529,952,000 | -220,357,000 | -80,963,000 | -1,045,662,000 | -524,381,000 | |
benefit from income taxes | -363,000 | -2,369,000 | -1,363,000 | -65,000 | 188,000 | 14,000 | 296,000 | 587,000 | 129,000 | -161,000 | 149,000 | 68,000 | 323,000 | 18,000 | 22,000 | |
net income | -978,428,000 | -539,432,000 | -366,171,000 | -643,390,000 | -680,859,000 | -653,766,000 | -630,894,000 | -764,232,000 | -779,528,000 | -472,648,000 | -530,101,000 | -220,425,000 | ||||
yoy | 52.07% | -20.77% | -43.99% | -15.81% | -12.66% | 38.32% | 19.01% | 246.71% | ||||||||
qoq | 81.38% | 47.32% | -5.50% | 4.14% | 3.63% | -17.45% | -1.96% | 64.93% | -10.84% | 140.49% | ||||||
net income margin % | -290.70% | -207.93% | -155.79% | -320.76% | -394.15% | -416.01% | -457.79% | -506.54% | -521.66% | -183.40% | -271.21% | -226.46% | 0% | 0% | 0% | |
accretion of redeemable convertible preferred stock | -56,121,000 | -199,823,000 | -364,925,000 | -3,901,000 | ||||||||||||
net income attributable to common stockholders, basic | -1,034,549,000 | -739,255,000 | -653,766,000 | -630,894,000 | -764,232,000 | -779,528,000 | -472,648,000 | -530,101,000 | -220,425,000 | |||||||
interest expense on 2026 notes | 309,000 | |||||||||||||||
net income attributable to common stockholders, diluted | -1,034,549,000 | -855,306,000 | -653,766,000 | -630,894,000 | -764,232,000 | -779,528,000 | -728,547,000 | -670,247,000 | -555,268,000 | |||||||
weighted-average shares outstanding attributable to common stockholders | ||||||||||||||||
basic | 312,166,297,000 | 3,056,404,834,000 | 2,445,176,539,000 | 2,081,772,622,000 | 2,284,446,783,000 | 1,912,459,833,000 | 1,831,725,009,000 | |||||||||
diluted | 312,166,297,000 | 3,057,882,724,000 | 2,445,176,539,000 | 2,081,772,622,000 | 2,284,446,783,000 | 1,912,459,833,000 | 1,831,725,009,000 | |||||||||
net income per share | -0.24 | -0.34 | -0.3 | -0.28 | -0.32 | -0.13 | -0.05 | 2.15 | -0.43 | |||||||
basic | -3.31 | -0.24 | -0.28 | -0.28 | -0.4 | -0.43 | ||||||||||
diluted | -3.31 | -0.28 | -0.28 | -0.28 | -0.4 | -0.43 | ||||||||||
other comprehensive income | ||||||||||||||||
net unrealized gains on investments, net of tax | 684 | 293 | 3,552 | -957 | -3,262 | 10,079 | 1,554 | -2,999 | 4,035 | |||||||
foreign currency translation adjustments | -2,187 | 8,973 | 3,897 | -802 | -3,988 | 5,134 | -1,967 | 586 | ||||||||
total other comprehensive income | -1,503 | 9,266 | 7,449 | -1,759 | -7,250 | 15,213 | -413 | -2,413 | ||||||||
comprehensive loss | -979,931 | -530,166 | -358,722 | -645,149 | -688,109 | -470,954 | -542,676 | -221,116 | ||||||||
comprehensive loss attributable to common stockholders | -1,036,052 | -729,989 | -723,647 | -792,010 | -692,010 | -638,553 | -631,307 | -766,645 | -775,493 | -470,954 | -542,676 | -221,116 | ||||
net income attributable to common stockholders, basic and diluted | -731,096,000 | -790,251,000 | -684,760,000 | |||||||||||||
weighted-average shares outstanding attributable to common stockholders, basic and diluted | 3,036,317,307,000 | 2,310,360,525,000 | 2,301,870,644,000 | |||||||||||||
net income per share | -0.24 | -0.34 | -0.3 | -0.28 | -0.32 | -0.13 | -0.05 | 2.15 | -0.43 | |||||||
change in fair value of derivative liability associated with series a redeemable convertible preferred stock | 103,000,000 | |||||||||||||||
accretion of series a redeemable convertible preferred stock | -146,861,000 | |||||||||||||||
change in fair value of dilutive warrants | -255,899,000 | -140,146,000 | -334,843,000 | |||||||||||||
change in fair value of forward contracts | ||||||||||||||||
change in fair value of convertible preferred stock warrant liability | ||||||||||||||||
transaction costs expensed | -2,717,000 | |||||||||||||||
deemed dividend related to the issuance of series e convertible preferred stock | ||||||||||||||||
weighted-average shares outstanding used in computing net income per share attributable to common stockholders, basic | 1,678,346,079 | 1,676,048,504 | 1,669,303,813 | |||||||||||||
weighted-average shares outstanding used in computing net income per share attributable to common stockholders, diluted | 1,693,258,608 | 1,690,963,548 | 1,686,815,404 | |||||||||||||
other comprehensive loss | ||||||||||||||||
net unrealized losses on investments, net of tax | 1,694 | -12,575 | -691 | |||||||||||||
other income, net: | ||||||||||||||||
net income and comprehensive loss | -81,286,000 | -1,045,680,000 | -524,403,000 | |||||||||||||
net income attributable to common stockholders | -81,286,000 | -1,045,680,000 | -524,403,000 | |||||||||||||
weighted-average shares outstanding used in computing net income per share attributable to common stockholders, basic and diluted | 1,654,322,379 | 740,393,759 | 1,217,032,285 | |||||||||||||
gross profit | -676,250 | -3,088,000 | ||||||||||||||
yoy | ||||||||||||||||
qoq | -78.10% | |||||||||||||||
gross margin % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | -2.56% | -1331.03% | |
operating expenses | ||||||||||||||||
total operating expenses | 260,514,250 | 493,962,000 |
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
